# Avery Dennison Corp: overview

AVY · NYSE · CIK 8818 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avy.md) · [Financials](/companies/avy/financials.md) · [Filings](/companies/avy/filings.md) · [Insiders](/companies/avy/insiders.md)

Latest reported revenue: [$2.46bn](/filings/0000008818-26-000131.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000008818-26-000131).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,183](/filings/0000008818-25-000049.md) | [2,186 d](/filings/0000008818-26-000015.md) | [2,148](/filings/0000008818-26-000109.md) | [2,221](/filings/0000008818-26-000131.md) | [2,216](/filings/0000008818-25-000049.md) | [2,271 d](/filings/0000008818-26-000015.md) | [2,299](/filings/0000008818-26-000109.md) | [2,463](/filings/0000008818-26-000131.md) |
| Gross margin | % | [28.7%](/filings/0000008818-25-000049.md) | [27.9% d](/filings/0000008818-26-000015.md) | [28.9%](/filings/0000008818-26-000109.md) | [28.8%](/filings/0000008818-26-000131.md) | [28.7%](/filings/0000008818-25-000049.md) | [28.7% d](/filings/0000008818-26-000015.md) | [28.9%](/filings/0000008818-26-000109.md) | [29.6%](/filings/0000008818-26-000131.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [8.3%](/filings/0000008818-25-000049.md) | [8.0% d](/filings/0000008818-26-000015.md) | [7.7%](/filings/0000008818-26-000109.md) | [8.5%](/filings/0000008818-26-000131.md) | [7.5%](/filings/0000008818-25-000049.md) | [7.3% d](/filings/0000008818-26-000015.md) | [7.3%](/filings/0000008818-26-000109.md) | [8.3%](/filings/0000008818-26-000131.md) |
| Diluted EPS | $ per share | [2.25](/filings/0000008818-25-000049.md) | not reported | [2.09](/filings/0000008818-26-000109.md) | [2.41](/filings/0000008818-26-000131.md) | [2.13](/filings/0000008818-25-000049.md) | not reported | [2.18](/filings/0000008818-26-000109.md) | [2.67](/filings/0000008818-26-000131.md) |
| Free cash flow | $m | [227 d](/filings/0000008818-25-000049.md) | [282 d](/filings/0000008818-26-000015.md) | [(52.3)](/filings/0000008818-26-000109.md) | [179 d](/filings/0000008818-26-000131.md) | [276 d](/filings/0000008818-25-000049.md) | [310 d](/filings/0000008818-26-000015.md) | [108](/filings/0000008818-26-000109.md) | [369 d](/filings/0000008818-26-000131.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-01) | FY2022 (2022-12-31) | FY2023 (2023-12-30) | FY2024 (2024-12-28) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8,408](/filings/0000008818-24-000003.md) | [9,039](/filings/0000008818-25-000003.md) | [8,364](/filings/0000008818-26-000015.md) | [8,756](/filings/0000008818-26-000015.md) | [8,856](/filings/0000008818-26-000015.md) |
| Gross margin | % | [27.5%](/filings/0000008818-24-000003.md) | [26.6%](/filings/0000008818-25-000003.md) | [27.2%](/filings/0000008818-26-000015.md) | [28.9%](/filings/0000008818-26-000015.md) | [28.8%](/filings/0000008818-26-000015.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [8.8%](/filings/0000008818-24-000003.md) | [8.4%](/filings/0000008818-25-000003.md) | [6.0%](/filings/0000008818-26-000015.md) | [8.1%](/filings/0000008818-26-000015.md) | [7.8%](/filings/0000008818-26-000015.md) |
| Diluted EPS | $ per share | [8.83](/filings/0000008818-24-000003.md) | [9.21](/filings/0000008818-25-000003.md) | [6.20](/filings/0000008818-26-000015.md) | [8.73](/filings/0000008818-26-000015.md) | [8.79](/filings/0000008818-26-000015.md) |
| Free cash flow | $m | [792](/filings/0000008818-24-000003.md) | [683](/filings/0000008818-25-000003.md) | [561](/filings/0000008818-26-000015.md) | [730](/filings/0000008818-26-000015.md) | [712](/filings/0000008818-26-000015.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/avy/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.05bn | 6,482,687 |  | Added +100,497 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $939.8m | 5,788,479 |  | Added +482,054 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $812.4m | 5,004,194 |  | Reduced −5,513 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $789.9m | 4,865,518 |  | Added +1,316 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $656.7m | 4,044,695 |  | Added +289,669 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $575.7m | 3,546,264 |  | Reduced −90,490 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $372.5m | 2,294,307 |  | Added +394,705 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $351.3m | 2,172,120 |  | Added +4,635 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $253.3m | 1,560,021 |  | Added +213,187 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $171.5m | 1,056,207 |  | Reduced −13,163 |

## Recent filings

[All 1,527 filings](/companies/avy/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 06:46 ET | [8-K](/filings/0000008818-26-000162.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000008818-26-000162 |
| 2026-10-13 | 06:46 ET | [8-K](/filings/0000008818-26-000157.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000008818-26-000157 |
| 2026-10-05 | 06:45 ET | [8-K](/filings/0000008818-26-000154.md) | 5.02 Departure or appointment of officers or directors | 0000008818-26-000154 |
| 2026-08-19 | 06:45 ET | [8-K](/filings/0000008818-26-000141.md) | 8.01 Other events | 0000008818-26-000141 |
| 2026-08-04 | 16:16 ET | [10-Q](/filings/0000008818-26-000131.md) | Quarterly report, period 2026-06-30 | 0000008818-26-000131 |
| 2026-07-30 | 06:47 ET | [8-K](/filings/0000008818-26-000127.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000008818-26-000127 |
| 2026-06-04 | 06:44 ET | [8-K](/filings/0000008818-26-000116.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000008818-26-000116 |
| 2026-05-05 | 18:25 ET | [10-Q](/filings/0000008818-26-000109.md) | Quarterly report, period 2026-03-31 | 0000008818-26-000109 |
| 2026-05-01 | 16:15 ET | [8-K](/filings/0000008818-26-000078.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000008818-26-000078 |
| 2026-04-28 | 06:46 ET | [8-K](/filings/0000008818-26-000075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000008818-26-000075 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000008818-26-000015.md), filed Feb 25, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/217ca514-bbb6-4fd2-bac1-54e4d5529dc7)

## About the filer

- CIK: 8818
- Tickers: AVY
- Exchange: NYSE
- SIC code: 2670 Converted Paper & Paperboard Prods (No Contaners/Boxes)
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 06:47 ET. No prices; not investment advice.